Statement from Hank C. K. Wuh, MD., MPH, Founder and CEO of SKAI Ventures:
“We are extremely humbled and grateful for this recognition. It is a great honor to be among so many amazing Hawaii companies who we highly respect as leaders of their respective industries. SKAI Ventures, together with the other winners from Hawaii Island, Maui, Kauai and Oahu, will do our very best to showcase Hawaii as a place where technology and innovation can impact the world.
Many talented and dedicated individuals have worked extremely hard over the years to help us fulfill the mission of SKAI Ventures – which is to invent the future, disrupt the status quo and inspire hope. We’d like to thank all these individuals and the APEC Host Committee for providing this wonderful opportunity to introduce Hawaii’s businesses to such a unique and influential audience.”
An eye care campus devoted to accelerating biomedical innovation, developing technologies to restore vision for the blind, and building an internationally recognized Vision Institute broke ground yesterday at Dole Cannery Shops in Iwilei.
The tech cluster includes SKAI Vision Institute, a global center for the restoration of vision; Cellular Bioengineering Inc. / Eyegenix, which develop and manufacture artificial cornea technology; SKAI Ventures, the parent venture accelerator focused on the transformation of ideas into technology companies in Hawaii; the Eye Surgery Center of Hawaii, an ophthalmic ambulatory surgery center; and World Children’s Vision, a nonprofit dedicated to bringing blind children to Honolulu for the gift of sight.
U.S. Sen. Daniel K. Inouye served as the keynote speaker. View the article here.
Hawaii soon could be a destination of choice for top-of-the-line eye care if a plan being launched b y Hank Wuh, founder of Honolulu-based Cellular Bioengineering, comes to fruition.
A ceremony announcing his plans for an $8 million campus, encompassing a portfolio of companies focusing on cutting-edge eye surgery and located in the Dole Cannery, was scheduled for today. Wuh and his team hope to tap into what they estimate is a billion-dollar market in eyesight restoration.